Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04338256 · ClinicalTrials.gov registry record
Mental Health Curriculum Study
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 295
- Enrollment target
NCT04338256: Completed study, sponsored by University of Pittsburgh.
NCT04338256 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 295 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04338256 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 295 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the acceptability, appropriateness, feasibility, and preliminary effectiveness of a college course grounded in skills from dialectical behavior therapy (DBT) titled, "Wellness and Resilience for College and Beyond." The study takes place on 5 college campuses in Pennsylvania and West Virginia offering the Wellness Course during the 2020 calendar year (Spring and Fall 2020 semesters). The Wellness Course is an undergraduate college course that includes 14 two and a half hour long lessons, weekly homework assignments and tracking of skills use via a "diary card," and a cumulative final exam at the end of the semester. Students who choose to enroll in the wellness course are offered the opportunity to enroll in the study and a comparison sample of students not enrolled are recruited from each site.
Primary Outcome
Acceptability of Intervention Measure (AIM) is a 4 item scale. Respondents provide ratings using Likert type ratings ranging from 1-5, where 1= completely disagree and 5=completely agree. The ratings are summed and the average is taken.
Interventions
- BEHAVIORAL Wellness and Resilience for College and Beyond (Undergraduate College Course)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 295 participants |
| Start Date | 2019-12-09 |
| Est. Completion | 2021-04-13 |
What the finished NCT04338256 record still lists
NCT04338256 is an observational study that tracks outcomes without assigning an intervention. The registered 295 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Wellness and Resilience for College and Beyond (Undergraduate College Course) is the first listed.
NCT04338256 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04338256 about?
NCT04338256 is a clinical study titled "Mental Health Curriculum Study". The purpose of this study is to investigate the acceptability, appropriateness, feasibility, and preliminary effectiveness of a college course grounded in skills from dialectical behavior therapy (DBT) titled, "Wellness and Resilience for College and Beyond." The study takes place on 5 college campu...
What is the current status of trial NCT04338256?
This trial is currently completed. The enrollment target is 295 participants. The study started on 2019-12-09. Estimated completion is 2021-04-13.
What interventions are being tested in trial NCT04338256?
The interventions under investigation include: Wellness and Resilience for College and Beyond (Undergraduate College Course) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04338256?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05201781 · 295 participants · Phase 4
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
- NCT06004245 · 295 participants · Phase 1
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
- NCT06494111 · 295 participants · Phase 2
Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)
- NCT07020221 · 295 participants · Phase 1
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI